Oral mucositis is a painful inflammation and ulceration of the mouth lining that develops as a side effect of cancer treatment. It affects nearly all patients receiving radiation to the head and neck area (98.6% develop some degree of it) and is one of the most common and debilitating complications of chemotherapy and radiation therapy. In severe cases, the sores become so painful that eating, drinking, and even speaking become difficult or impossible.
Why Cancer Treatment Damages the Mouth
The cells lining your mouth are among the fastest-dividing cells in your body, which makes them especially vulnerable to cancer treatments designed to kill rapidly growing cells. Both chemotherapy and radiation therapy injure these cells, either by directly damaging their DNA or by generating unstable molecules called reactive oxygen species. That initial damage triggers a cascade of inflammation: the body releases inflammatory signals that cause further tissue breakdown, which leads to open sores, which then attract bacteria that fuel even more inflammation. It becomes a self-reinforcing cycle of damage.
Eventually, the lining breaks down enough to form ulcers, the hallmark of severe mucositis. Once cancer treatment stops or the cycle is interrupted, the tissue begins to heal through new cell growth that gradually restores the protective barrier.
What It Looks and Feels Like
Oral mucositis ranges from mild redness to deep, widespread ulcers. The World Health Organization grades it on a scale from 0 to 4:
- Grade 1: Redness and soreness, but no ulcers. You can still eat normally.
- Grade 2: Red patches with ulcers forming. Solid foods become painful to swallow.
- Grade 3: Extensive ulcers with significant redness. You can only manage liquids.
- Grade 4: Ulceration so severe that eating and drinking by mouth are no longer possible, requiring nutrition through a feeding tube or IV.
The sores typically appear on the inner cheeks, the sides of the tongue, the floor of the mouth, and the soft palate. Pain can range from a mild burning sensation to intense, constant pain that interferes with sleep. Many people describe it as feeling like the inside of their mouth has been scalded.
How Common Is Severe Mucositis
In a cohort study of patients with head and neck cancer receiving intensity-modulated radiation therapy, 62.5% developed severe mucositis (grade 3 or 4) by the end of their treatment course. Chemotherapy-induced mucositis varies depending on the drug, but certain agents carry particularly high risk. Drugs that interfere with DNA synthesis are the worst offenders, including fluorouracil (5-FU), methotrexate, and cytarabine. Other common culprits include doxorubicin, cyclophosphamide, bleomycin, and paclitaxel.
Some chemotherapy drugs, notably methotrexate and etoposide, are secreted into saliva, which means they come into direct contact with the mouth lining and increase the risk further.
Who Is Most at Risk
Not everyone undergoing cancer treatment develops mucositis to the same degree. Several factors influence your risk. Younger patients tend to be more susceptible because their mouth lining cells divide faster, giving the treatment more targets. Older patients face risk from a different angle: declining kidney function can slow the clearance of chemotherapy drugs, prolonging their toxic effects on the mouth.
Poor oral hygiene before and during treatment significantly increases both the likelihood and severity of mucositis. Smoking compounds the problem. Nutritional status matters too. Patients who are malnourished going into treatment tend to fare worse, as do those with low white blood cell counts at the start of therapy.
Serious Complications
Oral mucositis is far more than a comfort issue. When the mouth lining breaks down, it removes a critical barrier between the bacteria in your mouth and your bloodstream. This is especially dangerous during chemotherapy, when your immune system is suppressed. A meta-analysis found that patients with oral mucositis had nearly four times the risk of developing infections compared to patients without it. Those infections ranged from bacterial bloodstream infections to fungal infections, and they were associated with longer hospital stays, higher treatment costs, and worse overall outcomes.
Severe mucositis also forces some patients to delay or reduce their cancer treatment doses, which can compromise the effectiveness of the therapy itself. The inability to eat adequately leads to nutritional deficiencies, dehydration, and weight loss that further weaken the body during an already demanding time.
Prevention Strategies That Work
Several preventive approaches have strong enough evidence that the Multinational Association of Supportive Care in Cancer (MASCC) formally recommends them.
Oral cryotherapy is one of the simplest. For patients receiving bolus 5-FU chemotherapy, holding ice chips in the mouth for 30 minutes during the infusion constricts blood vessels in the mouth lining, reducing the amount of drug that reaches those tissues. The same approach is recommended for patients undergoing stem cell transplants with high-dose melphalan conditioning.
Benzydamine mouthwash, an anti-inflammatory rinse, is recommended for patients receiving moderate-dose radiation (under 50 Gy) to the head and neck. It helps reduce the inflammatory component of mucositis before ulcers have a chance to form.
Photobiomodulation (low-level laser therapy) has become one of the most broadly recommended preventive treatments. Specific light wavelengths applied inside the mouth stimulate tissue repair and reduce inflammation. MASCC recommends it for patients receiving head and neck radiation (with or without chemotherapy) and for adults undergoing stem cell transplants. The treatments are painless and typically administered throughout the course of cancer therapy.
For patients with blood cancers receiving intensive chemotherapy before a stem cell transplant, palifermin is the only FDA-approved drug specifically indicated to reduce the incidence and duration of severe oral mucositis. It works by stimulating the growth of epithelial cells, essentially strengthening the mouth lining before the chemotherapy hits. It is given as a series of six IV injections, three before and three after treatment.
Managing Symptoms at Home
Good mouth care is the foundation of managing mucositis once it develops. Memorial Sloan Kettering Cancer Center recommends rinsing your mouth every four to six hours with a simple homemade solution: one quart (four cups) of water mixed with one teaspoon of salt and one teaspoon of baking soda. You can also use just salt or just baking soda if you prefer. These rinses help keep the mouth clean, soothe irritated tissue, and maintain a neutral environment that discourages bacterial overgrowth. Avoid commercial mouthwashes that contain alcohol, which will burn and dry out already damaged tissue.
Adjusting what you eat makes a significant difference in daily comfort. Soft, bland, room-temperature or cool foods are easiest to tolerate. Think mashed potatoes, yogurt, smoothies, scrambled eggs, and well-cooked pasta. Avoid anything acidic (citrus, tomatoes), spicy, rough-textured (chips, raw vegetables, toast), or very hot. At grade 3 or 4, a liquid diet or nutritional supplements may be the only option, and your care team may recommend a feeding tube to ensure you get adequate nutrition. Some evidence supports vitamin A and E supplements for helping with tissue repair, though this should be coordinated with your oncology team since supplements can sometimes interact with treatment.
How Long It Lasts
The timeline depends on the type of cancer treatment. With chemotherapy alone, mucositis generally appears within a few days to two weeks after treatment and resolves within two to four weeks once the offending drug is cleared from the body, assuming no new cycles begin. For radiation therapy to the head and neck, symptoms typically begin during the second or third week of treatment and can persist for several weeks after the final radiation session, since the tissue damage accumulates with each dose.
Patients receiving combined chemotherapy and radiation tend to experience the earliest onset and longest duration. Those undergoing stem cell transplants with high-dose conditioning regimens often face some of the most severe cases, with mucositis peaking around the time of the lowest white blood cell counts and gradually resolving as the new stem cells begin producing healthy blood cells. Complete healing involves the regrowth and restoration of the full mucosal barrier, a process that the body accomplishes through signaling that triggers new epithelial cell proliferation.